Inventor · disambiguated record
Ian Slaymaker
Also filed as: SLAYMAKER IAN
21 granted patents·20 pending applications·766 citations·filing 2015–2025
96Inventor score
Top patents by PatentIndex Score
41 records- 0198US12091709B2Crispr enzymes and systemsBROAD INST INC·Filed 2023·Granted Sep 17, 2024·7 cites·30 claims
- 0298US11091798B2CRISPR enzymes and systemsBROAD INST INC·Filed 2018·Granted Aug 17, 2021·32 cites·27 claims
- 0398US10876100B2Crispr enzyme mutations reducing off-target effectsBROAD INST INC·Filed 2017·Granted Dec 29, 2020·20 cites·29 claims
- 0498US10669540B2CRISPR enzymes and systemsBROAD INST INC·Filed 2017·Granted Jun 2, 2020·31 cites·41 claims
- 0598US10648020B2CRISPR enzymes and systemsBROAD INST INC·Filed 2017·Granted May 12, 2020·41 cites·15 claims
- 0698US10494621B2Crispr enzyme mutations reducing off-target effectsBROAD INST INC·Filed 2018·Granted Dec 3, 2019·35 cites·22 claims
- 0798US9790490B2CRISPR enzymes and systemsBROAD INST INC·Filed 2015·Granted Oct 17, 2017·534 cites·60 claims
- 0897US11634755B2Crispr enzymes and systemsBROAD INST INC·Filed 2021·Granted Apr 25, 2023·8 cites·30 claims
- 0996US11781172B2Crispr enzymes and systemsBROAD INST INC·Filed 2019·Granted Oct 10, 2023·10 cites·35 claims
- 1096US11773432B2CRISPR enzymes and systemsBROAD INST INC·Filed 2021·Granted Oct 3, 2023·11 cites·30 claims
- 1196US11344609B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2021·Granted May 31, 2022·6 cites·34 claims
- 1296US11142760B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2021·Granted Oct 12, 2021·14 cites·30 claims
- 1395US11752202B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2022·Granted Sep 12, 2023·3 cites·28 claims
- 1492US11155803B2Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequenceBEAM THERAPEUTICS INC·Filed 2020·Granted Oct 26, 2021·13 cites·30 claims
- 1587US12264359B2CRISPR enzymes and systemsBROAD INST INC·Filed 2020·Granted Apr 1, 2025·1 cites·47 claims
- 1687US2025179453A1Crispr enzyme mutations reducing off-target effectsBROAD INST INC·Filed 2024·Application pending·0 cites
- 1781US12016908B2Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·0 cites·14 claims
- 1880US2025250617A1Crispr enzymes and systemsBROAD INST INC·Filed 2025·Application pending·0 cites
- 1980US2025250618A1Crispr enzymes and systemsBROAD INST INC·Filed 2025·Application pending·0 cites
- 2079US2025101400A1Novel crispr enzymes and systemsBROAD INST INC·Filed 2024·Application pending·0 cites
- 2177US12410468B2CRISPR enzymes and systemsBROAD INST INC·Filed 2020·Granted Sep 9, 2025·0 cites·25 claims
- 2277US12371737B2CRISPR enzymes and systemsBROAD INST INC·Filed 2020·Granted Jul 29, 2025·0 cites·40 claims
- 2376US12123032B2CRISPR enzyme mutations reducing off-target effectsBROAD INST INC·Filed 2019·Granted Oct 22, 2024·0 cites·13 claims
- 2476US2024132867A1Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequenceBEAM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2570US2022235347A1Compositions and methods for treating hemoglobinopathiesBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2670US2024035006A1Crystal structure of crispr cpf1BROAD INST INC·Filed 2022·Application pending·0 cites
- 2767US2024228988A1Compositions and methods for efficient genome editingPRIME MEDICINE INC·Filed 2024·Application pending·0 cites
- 2859US2022364071A1Novel crispr enzymes and systemsBROAD INST INC·Filed 2019·Application pending·0 cites
- 2957US12410416B2CRISPR enzymes and systems with modified pam specificityBROAD INST INC·Filed 2017·Granted Sep 9, 2025·0 cites·23 claims
- 3055US11459557B2Use and production of CHD8+/− transgenic animals with behavioral phenotypes characteristic of autism spectrum disorderBROAD INST INC·Filed 2017·Granted Oct 4, 2022·0 cites·19 claims
- 3155US2022170027A1Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequenceBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3253US2023101597A1Compositions and methods for treating alpha-1 antitrypsin deficiencyBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3352US2022098593A1Splice acceptor site disruption of a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic diseaseBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3452US2022098572A1Nucleobase editors having reduced non-target deamination and assays for characterizing nucleobase editorsBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3552US2022136012A1Nucleobase editors having reduced off-target deamination and methods of using same to modify a nucleobase target sequenceBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3651US2022127594A1Compositions and methods for treating glycogen storage disease type 1aBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3750US2021317479A1Nucleic acid assemblies for use in targeted deliveryBROAD INST INC·Filed 2019·Application pending·0 cites
- 3848US2021163944A1Novel cas12b enzymes and systemsBROAD INST INC·Filed 2019·Application pending·0 cites
- 3947US2023140953A1Methods of editing a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic diseaseBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4046US2021130800A1Systems, methods, and compositions for targeted nucleic acid editingBROAD INST INC·Filed 2018·Application pending·0 cites
- 4144US2019264186A1Crystal structure of crispr cpf1BROAD INST INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ian Slaymaker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →